Amneal Pharmaceuticals
- Market cap
- 6.28B
- P/E (TTM)i
- 40.94
- P/Bi
- 190.78
- EPSi
- 0.22
- Div yieldi
- 0.00%
- 52W posi
- 87%
Anonymous reader poll. Unscientific, not investment advice.
About Amneal Pharmaceuticals
Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.
- Founded
- 2002
- CEO
- Mr. Robert A. Stewart
- Employees
- 8,500
- Headquarters
- Bridgewater, New Jersey, United States of America
- Fiscal year end
- 12-31
- Website
- amneal.com
Company profile
- Exchange
- US
- Symbol
- AMRX
- Market-cap rank
- #1854
- Listing date
- 1970-01-01
- Market cap
- 6.28B
- Float cap
- 3.75B
- Shares out
- 319.35M
- Float shares
- 190.89M
Sectors & themes
Quote time 2026-10-08 08:16:04 · For reference only, not investment advice and not tailored to your situation.